Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria. Part 1: The Myelodysplastic Syndromes (Aug 27, 2022 - Aug 26, 2025)
hosted byOpus Medicus, Inc.Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria. Part 1: The Myelodysplastic Syndromes is organized by Opus Medicus, Inc.
Course Dates:
Last Review Date: 27-Aug-2022
Expiration Date: 26-Aug-2025
Description:
This course is part 1 of a 3 part series that covers the diagnostic criteria and clinicopathologic features of the myelodysplastic syndromes (part 1), the myeloproliferative neoplasms (part 2), and acute myeloid leukemias (part 3).
Objectives:
• To delineate the specific diagnostic criteria for all WHO-defined myelodysplastic syndromes, including clinical, histologic, immunophenotypic, and genetic features.
• Differentiate the specific subtype of myelodysplastic syndrome in clinical cases using clinical, histologic, immunophenotypic, and genetic criteria.
Topics:
• Myelodyplastic syndromes (MDS) defined.
• Cytogenetic defects in myelodysplastic syndromes.
• Refractory cytopenia with unilineage dysplasia (RCUD).
• Refractory anemia with ring sideroblasts (RARS).
• Refractory cytopenia with multilineage dysplasia (RCMD).
• Refractory anemia with excess blasts (RAEB).
• Therapy-related MDS (tMDS).
• MDS with isoltaed del(5q).
• MDS, unclassifiable.
• Childhood MDS.
